Banquets and billions: How AstraZeneca sealed a US medicine deal with Trump

Core Points - AstraZeneca's CEO Pascal Soriot appeared relaxed during the announcement of a new medicine deal aimed at reducing drug prices for millions of Americans [1] Company Summary - The deal unveiled by U.S. President Donald Trump is expected to significantly impact AstraZeneca's market presence in the U.S. by making medications more affordable [1]